FOXO3公司
血管内皮生长因子A
医学
眼科
内皮功能障碍
血管内皮生长因子受体
内科学
生物
血管内皮生长因子
信号转导
遗传学
蛋白激酶B
作者
Wen‐Qing Shi,Bing Li,Yuting Shao,Wenting Han,Yule Xu,Jiang Qing,Shen Qu,Xiaodong Zhou,Yanlong Bi
摘要
Targeting EFEMP1 may offer a novel therapeutic strategy for the prevention and treatment of myopia by alleviating associated vascular dysregulation. Further exploration of the FOXO3/VEGFA pathway could provide additional insights into therapeutic interventions for myopia.
科研通智能强力驱动
Strongly Powered by AbleSci AI